A critical review of papers from clinical cancer research

Acta Oncologica

Volumn 37, Issue 4, 1998, Pages 339-346

  Skovlund, Eva ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER RESEARCH; CLINICAL RESEARCH; MEDICAL LITERATURE; METHODOLOGY; NORWAY; PRIORITY JOURNAL; PUBLICATION; STATISTICAL ANALYSIS;

EID: 0031926904     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418698430557     Document Type: Article

References (29)

1. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journals. Br J Cancer 1995; 72: 511-8.
2. Altman DG. Statistics in medical journals: developments in the 1980s. Stat Med 1991; 10: 1897-913.
3. Pocock SJ, Hughes MD, Lee RJ. Statistical problems in the reporting of clinical trials. A survey of three medical journals. N Engl J Med 1987; 317: 426-32.
4. Altman DG. Statistics in medical journals. Stat Med 1982; 1: 59-71.
5. Begg C, Cho M, Eastwood S, Norton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement, JAMA 1996; 276: 637-9.
6. Piantadosi S, Saijo N, Tamura T. Guidelines for analysis and reporting of clinical trials in oncology. Jpn J Cancer Res 1993; 84: 929-37.
7. Bailar JC, 3rd, Mosteller F. Guidelines for statistical reporting in articles for medical journals. Amplifications and explanations. Ann Intern Med 1988; 108: 266-73.
8. Gardner MJ, Machin D, Campbell MJ. Use of check lists in assessing the statistical content of medical studies. Br Med J Clin Res Ed 1986; 292: 810-2.
9. Simon R, Wittes RE. Methodologic guidelines for reports of clinical trials. Cancer Treat Rep 1985; 69: 1-3.
10. Zelen M. Guidelines for publishing papers on cancer clinical trials: responsibilities of editors and authors. J Clin Oncol 1983: 1: 164-9.
11. Altman DG, Gore SM, Gardner MJ, Pocock SJ. Statistical guidelines for contributors to medical journals. Br Med J Clin Res Ed 1983; 286: 1489-93.
12. Bailar JC, 3rd, Louis TA, Lavori PW, Polansky M. Studies without internal controls. N Engl J Med 1984; 311: 156-62.
13. Moses LE. The series of consecutive cases as a device for assessing outcomes of intervention. N Engl J Med 1984; 311: 705-10.
14. Mills JL. Data torturing (see comments). N Engl J Med 1993; 329: 1196-9.
15. Simon R, Altman DG. Statistical aspects of prognostic factor studies in oncology. Br J Cancer 1994; 69: 979-85.
16. Gardner MJ, Altman DG. Confidence intervals rather than values: estimation rather than hypothesis testing. Br Med J Clin Res Ed 1986; 292: 746-50.
17. Lent V, Langenbach A. A retrospective quality analysis of 102 randomized trials in four leading urological journals from 1984 1989. Urol Res 1996; 24: 119-22.
18. Andren Sandberg A, Cedercrantz C. Review of standards for reporting results of treatment of exocrine pancreatic cancer. Int J Pancreatol 1993; 14: 213-7.
19. Marsoni S, Torri W, Taiana A, et al. Critical review of the quality and development of randomized clinical trials (RCTs) and their influence on the treatment of advanced epithelial ovarian cancer. Ann Oncol 1990; 1: 343-50.
20. Nicolucci A, Grilli R, Alexanian AA, Apolone G, Torri V, Liberati A. Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta analysis. JAMA 1989; 262: 2101-7.
21. Zola P, Volpe T, Castelli G, et al. Is the published literature a reliable guide for deciding between alternative treatments for patients with early cervical cancer? Int J Radiat Oncol Biol Phys 1989; 16: 785-97.
22. Liberati A, Himel HN, Chalmers TC. A quality assessment of randomized control trials of primary treatment of breast cancer. J Clin Oncol 1986; 4: 942-51.
23. Meinert CL, Tonascia S, Higgins K. Content of reports on clinical trials: a critical review. Controlled Clinical Trials 1984; 5: 328-47.
24. Freiman JA, Chalmers TC, Smith H, Jr, Kuebler RR. The importance of beta, the type Il error and sample size in the design and interpretation of the randomized control trial. Survey of 71 'negative' trials. N Engl J Med 1978; 299: 690-4.
25. Mosteller F, Gilbert JP, McPeek B. Reporting standards and research strategies for controlled trials. Agenda for the editor. Controlled Clinical Trials 1980; 1: 37-58.
26. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994; 272: 122-4.
27. Hlatky MA. Using databases to evaluate therapy. Stat Med 1991; 10: 647-52.
28. Begg CB, Pocock SJ, Freedman L, Zelen M. State of the art in comparative cancer clinical trials. Cancer 1987; 60: 2811-5.
29. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet 1991; 337: 867-72.